Related Experiment Video
Updated: Jun 20, 2026
10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.4K
CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing
Nari Kim1, Mi-Hyun Kim2, Junhee Pyo3
1Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Biomedicines
|November 25, 2023
Summary
This study establishes C-C chemokine receptor 8 (CCR8) as a promising anti-cancer drug target. Bioinformatics analysis revealed CCR8
Area of Science:
- Oncology
- Bioinformatics
- Drug Discovery
Background:
- Target identification is critical in drug development for pinpointing disease-related genes and pathways.
- C-C chemokine receptor 8 (CCR8) has shown potential as an anti-cancer target, but multi-omics data across indications remain limited.
Purpose of the Study:
- To conduct a comprehensive bioinformatics analysis integrating multi-omics data to validate CCR8 as a viable anti-cancer drug target.
- To identify specific cancer types where CCR8 shows significant correlation for potential therapeutic intervention.
Main Methods:
- Integrated genomics, proteomics, and transcriptomics data from diverse knowledge resources.
- Performed gene function analysis, differential gene expression profiling, and immune cell infiltration assessment.
- Prioritized target indications based on integrated data analysis.
Main Results:
- Established strong correlations between CCR8 expression and several cancers, including Breast Invasive Carcinoma (BRCA), Colon Adenocarcinoma (COAD), Head and Neck Squamous Cell Carcinoma (HNSC), Rectum adenocarcinoma (READ), Stomach adenocarcinoma (STAD), and Thyroid carcinoma (THCA).
- Demonstrated the potential of CCR8 as a target for anti-cancer drug development across multiple solid tumor types.
Conclusions:
- CCR8 is a promising target for developing novel anti-cancer therapeutics.
- This research bridges molecular insights with therapeutic opportunities for personalized treatment of solid tumors.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...